Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,469,756
+$403,185 QoQ
Shares Held
1,347,866
-0.0% QoQ
Ownership
0.681%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 175 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $237,726,632 across 405 Biotechnology names. ABUS ranks #10 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
90,236 | $28,522,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,586 | $24,630,851 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
372,588 | $20,469,983 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
217,577 | $16,205,134 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
176,973 | $13,851,674 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
45,298 | $13,636,055 | |
| 7 | VCEL |
Vericel Corp
|
182,038 | $8,098,869 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,423 | $7,746,234 |
All Filings in ABUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,469,756 | 1,347,866 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,066,571 | 1,348,127 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,484,957 | 1,348,224 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,076,803 | 1,338,503 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,136,014 | 1,338,516 | Shares | Defined | 2025-09-04 | |
| 2025-03-31 | $4,693,721 | 1,344,906 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,405,749 | 1,347,324 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $5,283,562 | 1,372,354 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,232,802 | 1,369,839 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,528,250 | 1,367,539 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,418,847 | 1,367,539 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $2,777,119 | 1,368,039 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,144,189 | 1,367,039 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $4,170,864 | 1,376,523 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,207,298 | 1,376,523 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,606,238 | 1,364,523 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,697,857 | 1,364,523 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $4,066,280 | 1,364,524 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $5,309,437 | 1,364,894 | Shares | Defined | 2022-02-03 | |
| 2021-09-30 | $5,853,979 | 1,364,564 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $4,150,157 | 1,369,689 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $4,562,396 | 1,370,089 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,867,365 | 1,371,089 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $4,257,704 | 1,360,289 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,230,381 | 1,774,935 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,792,664 | 1,774,915 | Shares | Defined | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||